Cargando…
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
BACKGROUND: Gut microbiome (GM) composition and diversity have recently been studied as a biomarker of response to immune checkpoint blockade therapy (ICB) and of ICB-related colitis. AIM: To conduct a systematic review on the role of GM composition and diversity in predicting response and colitis i...
Autores principales: | Oey, Oliver, Liu, Yu-Yang, Sunjaya, Angela Felicia, Simadibrata, Daniel Martin, Khattak, Muhammad Adnan, Gray, Elin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724183/ https://www.ncbi.nlm.nih.gov/pubmed/36483977 http://dx.doi.org/10.5306/wjco.v13.i11.929 |
Ejemplares similares
-
Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022) -
Gut Microbiota and Immunotherapy
por: Xu, Xiaoqing, et al.
Publicado: (2022) -
Stromal inflammation, fibrosis and cancer: An old intuition with promising potential
por: Oey, Oliver, et al.
Publicado: (2023) -
Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
por: Limeta, Angelo, et al.
Publicado: (2020) -
Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer
por: Shoji, Fumihiro, et al.
Publicado: (2022)